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Um novo sistema híbrido para detecção simultânea de cafeína (CAF), dipirona (DIP) e de
ergotamina (ERG) foi desenvolvido para teste de preparações farmaceuticas. ERG foi determinada
por um sinal fluorimétrico, enquanto para CAF e DIP foi utilizado o método PLS-1 para resolução
de dados espectrométricos de UV-V. A curva de calibração da ERG foi linear na faixa de 2.5 - 10
mg L-1. O conjunto de calibrações constiui-se de 18 soluções com 0.5 a 4 mg L-1de CAF,  5 a 20
mg L-1 de DIP e de 2.5 e 10 mg L-1 de ERG. Não foi necessária a prepração de amostras anterior
à análise. Foram realizados estudos de recuperação com amostras reais obtendo-se resultados
altamente satisfatórios
A novel home-made hybrid detection system was designed for simultaneous determination
of caffeine (CAF), dipyrone (DIP) and ergotamine (ERG) in pharmaceutical preparations.
Thus, ERG was determined by a fluorimetric signal and PLS-1 method for resolving DIP and
CAF UV-V spectral data was used. The calibration curve for ERG was linear over the range 2.5 -
10 mg L-1. The calibration set consisted of 18 mixtures with 0.5 to 4 mg L-1 for CAF,  5 to 20
mg L-1 for DIP and 2.5 and 10 mg L-1 for ERG. Sample preparation prior to analysis was not
required. A recovery study with the real samples was carried out and the obtained results were
highly satisfactory.
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Introduction
Ergotamine tartrate [(5S’)-12’hydroxy-2’-methyl-
3’,6’,18-trioxo-5-benzyl ergotaman (2R, 3R)-tartrate],
(ERG); dipyrone [disodium salt of [(2,3-dihydro-1,5-
dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl] methylamino)
methanesulfonic acid], (DIP) and caffeine [1,3,7-
trimethylxanthine], (CAF) are usually joined in some
pharmaceutical preparations and in several formulations.
ERG is a sedative used to relieve migraine, DIP possesses
analgesic and antipyretic properties. The effect of these
drugs on relief pains can be enhanced when CAF is
present.
Chromatographic techniques are widely applied for
determining these analytes in pharmaceutical preparations,
but these methods present the disadvantages of relative
high cost, time consumption and use large volumes of toxic
organic solvents.1, 2
Methodologies such as FIA and SIA with spectrometric,
fluorimetric and biamperometric detection has been
reported for this purpose.3-9 Nevertheless, the simultaneous
determination of ERG, DIP and CAF was not found in the
literature.
The spectrophotometric and fluorimetric detection have
been used in the analysis of pharmaceuticals and biomedical
samples owing to lower cost of  instruments, the simplicity
of procedures, precision and accuracy, etc. Moreover, the
simultaneous determination of multicomponents in complex
samples by using these classical techniques is not possible
due to overlapping spectra.
On the other hand, the application of chemometric
techniques as PCR (Principal component regression), PLS1
and PLS2 (Partial least squares) to spectrophotometric and
fluorimetric data are being used for the analysis of complex
mixtures.10-16 In this paper a new analytical method with
home-made hybrid detection system for simultaneous
determination of CAF, DIP and ERG in pharmaceutical
preparations is  proposed.
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These kind of samples have such lower concentration
of ERG than the other two analytes, so it is necessary to
develop an original hybrid instrument that combines
features from both fluorimetric and spectrophotometric
detections.17 By this way it is possible the flourimetric
determination of ERG. CAF and DIP are determined by
using UV-V absorption spectral data and PLS-1.
Experimental
Apparatus
The home-made hybrid detection system was built
by using a Hewlett-Packard 8452A diode array
spectrophotometer controlled by a computer for UV–V
spectra acquisition. Moreover, four phototransistors, an
operational amplifier and a digital voltmeter Aka M-3850
to register the fluorescence signal were used.
By the other hand,  home made cell holder was
designed and a 10mm path length Hellma quartz cell was
employed.
Reagents
Analytical grade reagents and ultra pure water Milli-Q
quality (18.3 mΩ cm-1) were always used. Pure ergotamine,
caffeine and dipyrone were obtained from Saporitti.
The stock solutions of ergotamine, caffeine and dipyrone
were prepared by weighing 0.0025 g, 0.0025 g and 0.0253
g respectively, 2.5 mL of ethanol were added and then made
up to 50 mL with water. For dissolving these solutions an
ultrasonic bath was used for seven minutes.
The standard solutions were prepared by appropriate
dilution of the stock solutions and making up to 10.0 mL
with 10-4 mol L-1 NaOH.
Calibration and validation sets
The calibration set was obtained by applying a random
experimental design. A training set of 18 standard solutions
were prepared.  The concentration ranges  were 5 to 20
mg L-1 and 0.5 to 4 mg L-1 for DIP and  CAF, respectively.
The ERG of 2.5 and 10 mg L-1 was added to the mixtures.
Table 1 shows the composition of the calibration set. On
the other hand, a six mixtures validation set was prepared
in order to validate the chemometric models.
Sample preparation
The pharmaceutical samples were purchased from
local drugstores. The trade names were Migra Dioxadol
(BAGO), Tetralgil (CRAVERI) and Migral 500
(MONTPELLIER).
Twenty tablets of each one were weighed to calculate
the average tablet weight. They were finely powdered in
a mortar and homogenised. In order to obtain a solution
of approximately 4.0 mg L-1 of ERG, a suitable amount
of the powder was accurately weighed and dissolved in
an appropriate amount of ethanol (5% v/v), assisted by
an ultrasonic bath. Then,  making up to an adequate
volume with 10-4 mol L-1 NaOH and finally it was filtered
(Solution A).
In order to obtain approximately 12 mg L-1 of DIP and
2.5 mg L-1 of CAF a suitable dilution of Solution A was
carried out with 10-4 mol L-1 NaOH.
Results and Discussion
The relationship of DIP, CAF and ERG in commercial
pharmaceutical products is 500:100:1 mg/tablet so all the
analytical studies were carried out by considering this
proportion.
In order to select the optimum medium for the
simultaneous spectrophotometric determination of the
three analytes, different solvents and pH (HCl, NaOH, NH3
and 20% v/v ethanol) were tested. Every time, CAF and
DIP presented higher absorbances than ERG, which gave
hardly absorption (Figure 1). As the CAF and DIP spectra
overlapped the low ERG signal prevented the simultaneous
determination of the three analytes.
The same study was carried out by using fluorimetic
technique. CAF and DIP were not fluorescent in the tested
Table 1. Concentration level of DIP, CAF and ERG for calibration set
 Mixtures Dipyrone/ Caffeine/ Ergotamine/
(mg L-1) (mg L-1) (mg L-1)
M1 5.00 0.50 2.50
M2 20.00 0.50 2.50
M3 5.00 4.00 2.50
M4 20.00 4.00 2.50
M5 12.50 2.25 2.50
M6 12.50 2.25 2.50
M7 5.00 0.50 10.00
M8 20.00 0.50 10.00
M9 5.00 4.00 10.00
M10 20.00 4.00 10.00
M11 12.50 2.25 10.00
M12 12.50 2.25 10.00
M13 5.00 0.50 2.50
M14 20.00 0.50 10.00
M15 5.00 4.00 2.50
M16 20.00 4.00 10.00
M17 12.50 2.25 2.50
M18 12.50 2.25 10.00
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experimental conditions, while ERG has an important
signal. The best results for ERG were obtained by using
10-4 mol L-1 NaOH solution.
Bearing in mind these considerations and taking into
account that only ERG is fluorescent, it was decided to
design an hybrid system providing simultaneously
UV-Vis spectra to determine CAF and DIP and fluorimetric
signals for ERG determination.
Hybrid system
The hybrid system was designed in our laboratory
(Figure 2).
For this purpose, a polypropilene tube (length: 11.5
cm, inner diameter: 2.0 cm) was placed instead of the cell
holder of the spectrophotometer. The tube is black to
prevent radiation loss and it has a square hole (15×15
mm) to permit the insertion of a cuvette. Moreover, two
phototransistors were placed on each side of the tube, near
the sidewalls of the cell (Figure 2 b).
The radiation emitted by the deuterium lamp of the
spectrophotometer went on the rail tube and through the
cell. The UV-Vis spectra were recorded by the
spectrophotometer while the fluorescence signal was
detected by the phototransistors at 90 degree. The output
of the latter is amplified with an operational amplifier,
and the amplified output is read with a digital voltmeter
connected to the device through panel jacks.
Analytical parameters
The calibration curve of ERG was F = (0.105 ± 0.002)
X + (0.196 ± 0.013) where F is the fluorescent signal
and X is the concentration of ERG in mg L-1, with a
correlation coefficient of 0.995. The linear range was
2.50-10.00 mg L-1.
The reproducibility (RSD%) was 1.97%, calculated
from ten replicates containing 2.50 mg L-1.
PLS-1 method for resolving DIP and CAF spectral
data, was used. The number of factors was selected by
using the leave-one-out cross-validation method. The
optimum number of factors was obtained following the
statistics criterion of Haaland and Thomas.18 The
appropriated wavelengths regions were selected by
checking different wavelength ranges. In Table 2 were
shown the different figures of merit: the spectral range,
the number of factors for each analyte, the relative error
of prediction (REP%), selectivity (SEL) and sensitivity
(SEN).19
Applications to real samples
The proposed method was applied for the
determination of ERG, DIP and CAF in pharmaceutical
formulations.  In order to validate  the obtained results,
a recovery study was carried out.  Table 3 shows these
results  and as it can be seen, there are very good
recovery values, all in the recommended range by
Pharmacopoeia.20
Table 2. PLS calibration figures
Figures Dipyrone Caffeine
Spectral region / (nm) 270-330 210-290
Optimal number of factors 3 3
REP (%) 6.8 19.3
SEN 0.01 0.145
SEL 0.13 0.45
Figure 1. CAF (10 mg L-1),  DIP (50 mg L-1) and ERG (1 mg L -1) spectra.
Figure 2.  a) Hybrid system;  b) Cell holder (top view).
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Conclusions
The most important goal of this work was the
possibility to carry out a simultaneous determination of
the three analytes by using different techniques as
fluorimetry for ERG and spectrophotometry assisted by
chemometric tool for DIP and CAF.
For this purpose a home made hybrid system was
developed. This system is simple, cheap, easy to built and
with a fast data collection.
The results obtained applying this system showed a
good accuracy and reproducibility for these kind of
samples. So, this proposed method is a good alternative to
those of the Pharmacopoeia.
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